Clinical Research Fellow
Centre for Tumour Biology
Clinical Specialty: Clinical Oncology

Understanding and targeting c-Met in bladder cancer

Advanced bladder cancer kills approximately 5000 patients in the UK every year with no major advances in management for the last 2 decades.

My project aims to evaluate a promising drug target, c-Met, which has been found to be present at high levels in patients with advanced bladder cancer. We will explore the mechanism(s) by which c-Met signals and the effects of its inhibition in advanced bladder cancer.

See other researchers working on:

Cell Signalling Genitourinary Cancer
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.